Frontier IP Group（8WT）株式概要フロンティアIPグループ社は、子会社を通じて、英国の大学、研究者、科学者、技術者が開発した知的財産の商業化に取り組んでいる。 詳細8WT ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性5/6配当金0/6リスク分析収益が 100 万ドル未満 ( £-4M )過去5年間で収益は年間68%減少しました。 German市場と比較して、過去 3 か月間の株価の変動が非常に大きい過去1年間で株主の希薄化は大幅に進んだ +1 さらなるリスクすべてのリスクチェックを見る8WT Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW479,582 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA479,582 investors already sharing narrativesYour Fair Value€Current Price€0.13該当なし内在価値ディスカウントEst. Revenue$PastFuture-8m21m2016201920222025202620282031Revenue UK£0.005Earnings UK£0.002AdvancedSet Fair ValueView all narrativesFrontier IP Group Plc 競合他社Eight Capital PartnersSymbol: DB:ECS0Market cap: €19.8mMountain AllianceSymbol: XTRA:ECFMarket cap: €23.4mKST BeteiligungsSymbol: DB:KSWMarket cap: €4.1mConsulting Team HoldingSymbol: DUSE:5GGMarket cap: €16.5m価格と性能株価の高値、安値、推移の概要Frontier IP Group過去の株価現在の株価UK£0.1352週高値UK£0.2752週安値UK£0.07ベータ0.491ヶ月の変化14.29%3ヶ月変化1.59%1年変化-43.86%3年間の変化-74.90%5年間の変化n/aIPOからの変化-89.59%最新ニュースNew Risk • Jul 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 63% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (48% average weekly change). Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (63% increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (€18.2m market cap, or US$20.8m).お知らせ • Jun 19Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,333,333 Price\Range: £0.12 Transaction Features: Rights Offeringお知らせ • Jun 17+ 2 more updatesFrontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £4 million.Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 32,329,324 Price\Range: £0.12 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,004,007 Price\Range: £0.12 Transaction Features: Regulation S; Subsequent Direct ListingBoard Change • May 21Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Nigel Grierson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • May 06+ 1 more updateFrontier IP Group Plc Announces the Appointment of Shaun Claydon as Company Secretary, Effective 5 May 2026Frontier IP announced the appointment of Shaun Claydon as Company Secretary with immediate effect from 5 May 2026. Shaun is an ICAEW-qualified chartered accountant with extensive experience in corporate finance, scaling businesses, and delivering successful exits. He brings more than 20 years' experience in senior financial leadership roles, including more than 15 years at board-level, with a focus on fundraising, mergers and acquisitions ("M&A"), and growth strategy. Shaun has held board-level positions in a number of private and public companies, most recently as Chief Financial Officer at Actimed Therapeutics, where he co-led a Series B equity funding round securing a multi-million investment for clinical programmes. Prior to this Shaun served as Chief Financial Officer of Destiny Pharma for six years between 2018 and 2024. Before transitioning to executive roles, Shaun gained extensive experience in financial consultancy and senior corporate finance roles including at HSBC Investment Banking, BDO LLP, Evolution Securities plc and PwC. He is currently a non-executive director of spirits group Distil plc. Further to the announcement made by the Company on 6 November 2025, Jo Stent, previous Chief Financial Officer of the Group, has now stepped down from the Group's Board. However, Jo will remain employed with the Group for an additional short period of time to ensure an orderly handover of responsibilities to Shaun and to provide additional support on both a corporate level and with certain portfolio companies. Shaun Claydon, aged 57, is, or has been, a director or partner of the following companies or partnerships during the previous five years: Current directorships and/or partnerships: Distil plc; Former directorships and/or partnerships within the last five years: Destiny Pharma Limited; Destiny Pharma (Brighton) Limited; Destiny Pharma EU Limited (Ireland). Shaun Claydon was previously a director of Destiny Pharma Limited ("Destiny") (formerly known as Destiny Pharma plc) until 30 September 2024. Destiny appointed an administrator on 21 August 2024 and was placed into creditors' voluntary liquidation on 1 August 2025.お知らせ • Dec 17+ 2 more updatesFrontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.870588 million.Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.870588 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 4,487,658 Price\Range: £0.155 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,129,036 Price\Range: £0.155 Transaction Features: Regulation S; Subsequent Direct Listing最新情報をもっと見るRecent updatesNew Risk • Jul 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 63% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (48% average weekly change). Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (63% increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (€18.2m market cap, or US$20.8m).お知らせ • Jun 19Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,333,333 Price\Range: £0.12 Transaction Features: Rights Offeringお知らせ • Jun 17+ 2 more updatesFrontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £4 million.Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 32,329,324 Price\Range: £0.12 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,004,007 Price\Range: £0.12 Transaction Features: Regulation S; Subsequent Direct ListingBoard Change • May 21Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Nigel Grierson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • May 06+ 1 more updateFrontier IP Group Plc Announces the Appointment of Shaun Claydon as Company Secretary, Effective 5 May 2026Frontier IP announced the appointment of Shaun Claydon as Company Secretary with immediate effect from 5 May 2026. Shaun is an ICAEW-qualified chartered accountant with extensive experience in corporate finance, scaling businesses, and delivering successful exits. He brings more than 20 years' experience in senior financial leadership roles, including more than 15 years at board-level, with a focus on fundraising, mergers and acquisitions ("M&A"), and growth strategy. Shaun has held board-level positions in a number of private and public companies, most recently as Chief Financial Officer at Actimed Therapeutics, where he co-led a Series B equity funding round securing a multi-million investment for clinical programmes. Prior to this Shaun served as Chief Financial Officer of Destiny Pharma for six years between 2018 and 2024. Before transitioning to executive roles, Shaun gained extensive experience in financial consultancy and senior corporate finance roles including at HSBC Investment Banking, BDO LLP, Evolution Securities plc and PwC. He is currently a non-executive director of spirits group Distil plc. Further to the announcement made by the Company on 6 November 2025, Jo Stent, previous Chief Financial Officer of the Group, has now stepped down from the Group's Board. However, Jo will remain employed with the Group for an additional short period of time to ensure an orderly handover of responsibilities to Shaun and to provide additional support on both a corporate level and with certain portfolio companies. Shaun Claydon, aged 57, is, or has been, a director or partner of the following companies or partnerships during the previous five years: Current directorships and/or partnerships: Distil plc; Former directorships and/or partnerships within the last five years: Destiny Pharma Limited; Destiny Pharma (Brighton) Limited; Destiny Pharma EU Limited (Ireland). Shaun Claydon was previously a director of Destiny Pharma Limited ("Destiny") (formerly known as Destiny Pharma plc) until 30 September 2024. Destiny appointed an administrator on 21 August 2024 and was placed into creditors' voluntary liquidation on 1 August 2025.お知らせ • Dec 17+ 2 more updatesFrontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.870588 million.Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.870588 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 4,487,658 Price\Range: £0.155 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,129,036 Price\Range: £0.155 Transaction Features: Regulation S; Subsequent Direct Listingお知らせ • Dec 09Frontier IP Group Plc, Annual General Meeting, Dec 31, 2025Frontier IP Group Plc, Annual General Meeting, Dec 31, 2025. Location: the offices of addleshaw goddard llp, exchange tower, 19 canning street, eh3 9eh, edinburgh United Kingdomお知らせ • Nov 09+ 1 more updateFrontier Ip Announces Resignation of Jo Stent as Director, Effective No Later Than 30 April 2026Frontier IP announced that Chief Financial Officer Jo Stent is to leave the Group to pursue an opportunity with a private equity backed specialist financial services provider. The Board of Frontier IP and Jo have agreed that Jo will step down as a director no later than 30 April 2026. The process to appoint a new Chief Financial Officer has commenced and an update will be provided in due course.お知らせ • Sep 27Matthew White Decides to Leave as Chief Commercialisation Officer of Frontier IP Group Plc, Effective March 24, 2026Frontier IP Group Plc announced that Matthew White (Chief Commercialisation Officer) has decided to leave the Group to pursue an opportunity as Chief Executive Officer of a Cambridge based early-stage medical devices company. It is currently intended that Mr. White will remain with the Company as Chief Commercialisation Officer and an Executive Director of the Company until the end of his six month notice period on 24 March 2026.お知らせ • Nov 26Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.47132 million.Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.47132 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,683,286 Price\Range: £0.28お知らせ • Nov 24Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £1 million.Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,571,428 Price\Range: £0.28お知らせ • Nov 23+ 1 more updateFrontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £3.030431 million.Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £3.030431 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 357,143 Price\Range: £0.28 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 9,422,968 Price\Range: £0.28 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,042,857 Price\Range: £0.28 Transaction Features: Regulation S; Subsequent Direct ListingNew Risk • Sep 30New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Revenue is less than US$5m (UK£816k revenue, or US$1.1m). Market cap is less than US$100m (€22.5m market cap, or US$25.2m).お知らせ • Apr 12Frontier IP Group plc Announces CFO Changes, Effective from April 22, 2024Frontier IP Group Plc announced the appointment of Jo Stent as Chief Financial Officer with effect from 22 April 2024. Jo is a chartered accountant, having qualified at Ernst & Young, and brings nearly 30 years' experience in senior financial roles across a broad range of sectors and geographies. Jo was most recently CFO at AIM quoted Argentex Group Plc, provider of bespoke currency risk management and payment solutions, from February 2021 to January 2024. She was previously Chief Financial Officer of the European Tour and Ryder Cup Europe. She is also a former CFO of Vodafone Americas and previously held senior positions at Telus Communications and Deloitte. Jo has spent most of her career in blue chip global organisations. More recently her keen interest in technology, innovation and scale up has led her to focus on working alongside founder led growth organizations as both an executive and non-executive director in the listed and private sector. With effect from 22 April 2024, Jim Fish, current Chief Financial Officer of the Group, will move to a new position within the Group as Portfolio Finance Director where he will continue to support the Group's portfolio companies.Reported Earnings • Mar 18First half 2024 earnings released: EPS: UK£0.027 (vs UK£0.005 in 1H 2023)First half 2024 results: EPS: UK£0.027 (up from UK£0.005 in 1H 2023). Net income: UK£1.49m (up 453% from 1H 2023).New Risk • Mar 14New major risk - Revenue and earnings growthEarnings have declined by 6.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Revenue is less than US$5m (UK£816k revenue, or US$1.0m). Market cap is less than US$100m (€27.6m market cap, or US$30.1m).New Risk • Jan 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (€26.6m market cap, or US$28.9m).Board Change • Jan 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Nigel Grierson was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Nov 29Frontier Ip Group plc Announces resignation of Jim Fish as Chief Financial OfficerFrontier IP Group Plc announced that Jim Fish has notified the Board of his intention to step down as Chief Financial Officer of the Group after 10 years of service. Jim, age 66, will remain as CFO and as a director of the Group through his six month notice period which will end no later than 31 May 2024. Jim will remain focused on running the Group's finance function and continue to support the Group during his six month notice period. Jim will also work to ensure the effective transition of his responsibilities to his successor with the intention that there will be an orderly handover period of three months. Following the appointment of a new Group CFO and the completion of the necessary handover period, Jim will take up a new position within the Group as Portfolio Finance Director where he will continue to support the portfolio companies and will report into the Group CEO. This change is in line with the Group's succession planning and the search for a new Group CFO has been initiated. A further announcement will be made in due course.お知らせ • Nov 23Frontier IP Group Plc, Annual General Meeting, Dec 15, 2023Frontier IP Group Plc, Annual General Meeting, Dec 15, 2023, at 11:00 Coordinated Universal Time. Location: 93 George Street, Edinburgh, EH2 3ES United Kingdom United Kingdom Agenda: To receive the audited consolidated financial statements of the Company and its subsidiaries for the year ended 30 June 2023, together with the reports of the Directors and the Auditor thereon; to approve the report of the Board to the members on directors' remuneration for the year ended 30 June 2023; to consider Retirement and Re-appointment of Directors; to resolve not to fill the vacancy created by the retirement of Andrew Richmond as a Director and Chairman of the Company at the AGM, in accordance with the Articles of Association of the Company; to re-appoint BDO LLP as auditor of the Company to hold office until the conclusion of the next general meeting at which financial statements are laid before shareholders; to authorize the Directors to determine the auditor's remuneration; to consider Authority to allot shares; and to consider any other matters.Reported Earnings • Nov 02Full year 2023 earnings released: UK£0.058 loss per share (vs UK£0.19 profit in FY 2022)Full year 2023 results: UK£0.058 loss per share (down from UK£0.19 profit in FY 2022). Net loss: UK£3.24m (down 132% from profit in FY 2022).お知らせ • Oct 31Frontier IP Group plc Announces Board ChangesFrontier IP announced that Andrew Richmond, currently Non-Executive Chairman, will be stepping down from the board of Frontier IP having served on the board for more than 11 years. Andrew will remain on the board until the Company's next annual general meeting ("AGM"), expected to be held in December 2023, where he will not seek re-election as a director. Dame Julia King, Baroness Brown of Cambridge, who joined the Frontier IP board of directors in October 2021 and is currently the Senior Independent Director on the board, will assume the role of Chair with effect from the conclusion of the forthcoming AGM.お知らせ • Oct 24Frontier IP Group Plc (AIM:FIPP) acquired 32.8% stake in Deakin Bio-Hybrid Materials Limited.Frontier IP Group Plc (AIM:FIPP) acquired 32.8% stake in Deakin Bio-Hybrid Materials Limited on October 23, 2023. Nick Athanas and George Payne of Allenby Capital Limited acted as financial advisor to Frontier IP Group. Frontier IP Group Plc (AIM:FIPP) completed the acquisition of 32.8% stake in Deakin Bio-Hybrid Materials Limited on October 23, 2023.New Risk • Oct 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Revenue is less than US$5m (UK£2.9m revenue, or US$3.6m). Market cap is less than US$100m (€34.7m market cap, or US$36.7m).New Risk • Jul 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Revenue is less than US$5m (UK£2.9m revenue, or US$3.8m). Market cap is less than US$100m (€28.7m market cap, or US$32.1m).Reported Earnings • Mar 16First half 2023 earnings released: EPS: UK£0.005 (vs UK£0.14 in 1H 2022)First half 2023 results: EPS: UK£0.005 (down from UK£0.14 in 1H 2022). Revenue: UK£910.0k (down 93% from 1H 2022). Net income: UK£269.0k (down 97% from 1H 2022). Profit margin: 30% (down from 66% in 1H 2022). The decrease in margin was driven by lower revenue.Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Julia King was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Nov 11Frontier IP Group Plc, Annual General Meeting, Dec 09, 2022Frontier IP Group Plc, Annual General Meeting, Dec 09, 2022, at 11:00 Coordinated Universal Time. Location: 93 George Street, Edinburgh, EH2 3ES Edinburgh United KingdomReported Earnings • Oct 28Full year 2022 earnings released: EPS: UK£0.19 (vs UK£0.17 in FY 2021)Full year 2022 results: EPS: UK£0.19 (up from UK£0.17 in FY 2021). Revenue: UK£14.1m (up 11% from FY 2021). Net income: UK£10.2m (up 6.9% from FY 2021). Profit margin: 73% (down from 76% in FY 2021). The decrease in margin was driven by higher expenses.お知らせ • Aug 02Frontier IP Group Plc Common Shares to Be Deleted from OTC EquityFrontier IP Group Plc Common Shares (United Kingdom) will be deleted from OTC Equity effective from August 02, 2022, due to CUSIP Suspended.Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Julia King was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to €1.03, the stock trades at a trailing P/E ratio of 3.4x. Average trailing P/E is 14x in the Capital Markets industry in Germany.Board Change • Dec 13Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Julia King was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Oct 29Full year 2021 earnings released: EPS UK£0.17 (vs UK£0.088 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: UK£12.7m (up 99% from FY 2020). Net income: UK£9.57m (up 129% from FY 2020). Profit margin: 76% (up from 66% in FY 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • Oct 21Investor sentiment improved over the past weekAfter last week's 16% share price gain to €1.42, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 18x in the Capital Markets industry in Germany.Board Change • Oct 02Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. 2 independent directors (5 non-independent directors). Non-Executive & Independent Director Mike Bourne was the last independent director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.株主還元8WTDE Capital MarketsDE 市場7D-7.2%-1.2%0.1%1Y-43.9%10.9%-0.5%株主還元を見る業界別リターン: 8WT過去 1 年間で10.9 % の収益を上げたGerman Capital Markets業界を下回りました。リターン対市場: 8WTは、過去 1 年間で-0.5 % のリターンを上げたGerman市場を下回りました。価格変動Is 8WT's price volatile compared to industry and market?8WT volatility8WT Average Weekly Movement48.3%Capital Markets Industry Average Movement4.0%Market Average Movement5.3%10% most volatile stocks in DE Market12.7%10% least volatile stocks in DE Market2.7%安定した株価: 8WTの株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 8WTの 週次ボラティリティ は、過去 1 年間で34%から48%に増加しました。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/a14Neil Crabbwww.frontierip.co.ukフロンティアIPグループ（Frontier IP Group Plc）は、子会社を通じて、英国の大学、学者、科学者、エンジニアが開発した知的財産の商業化に取り組んでいる。投資アドバイザリー、マーケティングサービスも提供。本拠地は英国ロンドン。もっと見るFrontier IP Group Plc 基礎のまとめFrontier IP Group の収益と売上を時価総額と比較するとどうか。8WT 基礎統計学時価総額€17.75m収益（TTM）-€9.22m売上高(TTM)n/a-4.3xP/Sレシオ-1.9xPER（株価収益率8WT は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計8WT 損益計算書（TTM）収益-UK£3.56m売上原価UK£0売上総利益-UK£3.56mその他の費用UK£4.32m収益-UK£7.88m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.07グロス・マージン100.00%純利益率221.29%有利子負債／自己資本比率0%8WT の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/23 23:34終値2026/07/23 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Frontier IP Group Plc 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • Jul 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 63% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (48% average weekly change). Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (63% increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (€18.2m market cap, or US$20.8m).
お知らせ • Jun 19Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,333,333 Price\Range: £0.12 Transaction Features: Rights Offering
お知らせ • Jun 17+ 2 more updatesFrontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £4 million.Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 32,329,324 Price\Range: £0.12 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,004,007 Price\Range: £0.12 Transaction Features: Regulation S; Subsequent Direct Listing
Board Change • May 21Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Nigel Grierson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • May 06+ 1 more updateFrontier IP Group Plc Announces the Appointment of Shaun Claydon as Company Secretary, Effective 5 May 2026Frontier IP announced the appointment of Shaun Claydon as Company Secretary with immediate effect from 5 May 2026. Shaun is an ICAEW-qualified chartered accountant with extensive experience in corporate finance, scaling businesses, and delivering successful exits. He brings more than 20 years' experience in senior financial leadership roles, including more than 15 years at board-level, with a focus on fundraising, mergers and acquisitions ("M&A"), and growth strategy. Shaun has held board-level positions in a number of private and public companies, most recently as Chief Financial Officer at Actimed Therapeutics, where he co-led a Series B equity funding round securing a multi-million investment for clinical programmes. Prior to this Shaun served as Chief Financial Officer of Destiny Pharma for six years between 2018 and 2024. Before transitioning to executive roles, Shaun gained extensive experience in financial consultancy and senior corporate finance roles including at HSBC Investment Banking, BDO LLP, Evolution Securities plc and PwC. He is currently a non-executive director of spirits group Distil plc. Further to the announcement made by the Company on 6 November 2025, Jo Stent, previous Chief Financial Officer of the Group, has now stepped down from the Group's Board. However, Jo will remain employed with the Group for an additional short period of time to ensure an orderly handover of responsibilities to Shaun and to provide additional support on both a corporate level and with certain portfolio companies. Shaun Claydon, aged 57, is, or has been, a director or partner of the following companies or partnerships during the previous five years: Current directorships and/or partnerships: Distil plc; Former directorships and/or partnerships within the last five years: Destiny Pharma Limited; Destiny Pharma (Brighton) Limited; Destiny Pharma EU Limited (Ireland). Shaun Claydon was previously a director of Destiny Pharma Limited ("Destiny") (formerly known as Destiny Pharma plc) until 30 September 2024. Destiny appointed an administrator on 21 August 2024 and was placed into creditors' voluntary liquidation on 1 August 2025.
お知らせ • Dec 17+ 2 more updatesFrontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.870588 million.Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.870588 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 4,487,658 Price\Range: £0.155 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,129,036 Price\Range: £0.155 Transaction Features: Regulation S; Subsequent Direct Listing
New Risk • Jul 17New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 63% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (48% average weekly change). Earnings have declined by 68% per year over the past 5 years. Shareholders have been substantially diluted in the past year (63% increase in shares outstanding). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (€18.2m market cap, or US$20.8m).
お知らせ • Jun 19Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,333,333 Price\Range: £0.12 Transaction Features: Rights Offering
お知らせ • Jun 17+ 2 more updatesFrontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £4 million.Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 32,329,324 Price\Range: £0.12 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,004,007 Price\Range: £0.12 Transaction Features: Regulation S; Subsequent Direct Listing
Board Change • May 21Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Nigel Grierson was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • May 06+ 1 more updateFrontier IP Group Plc Announces the Appointment of Shaun Claydon as Company Secretary, Effective 5 May 2026Frontier IP announced the appointment of Shaun Claydon as Company Secretary with immediate effect from 5 May 2026. Shaun is an ICAEW-qualified chartered accountant with extensive experience in corporate finance, scaling businesses, and delivering successful exits. He brings more than 20 years' experience in senior financial leadership roles, including more than 15 years at board-level, with a focus on fundraising, mergers and acquisitions ("M&A"), and growth strategy. Shaun has held board-level positions in a number of private and public companies, most recently as Chief Financial Officer at Actimed Therapeutics, where he co-led a Series B equity funding round securing a multi-million investment for clinical programmes. Prior to this Shaun served as Chief Financial Officer of Destiny Pharma for six years between 2018 and 2024. Before transitioning to executive roles, Shaun gained extensive experience in financial consultancy and senior corporate finance roles including at HSBC Investment Banking, BDO LLP, Evolution Securities plc and PwC. He is currently a non-executive director of spirits group Distil plc. Further to the announcement made by the Company on 6 November 2025, Jo Stent, previous Chief Financial Officer of the Group, has now stepped down from the Group's Board. However, Jo will remain employed with the Group for an additional short period of time to ensure an orderly handover of responsibilities to Shaun and to provide additional support on both a corporate level and with certain portfolio companies. Shaun Claydon, aged 57, is, or has been, a director or partner of the following companies or partnerships during the previous five years: Current directorships and/or partnerships: Distil plc; Former directorships and/or partnerships within the last five years: Destiny Pharma Limited; Destiny Pharma (Brighton) Limited; Destiny Pharma EU Limited (Ireland). Shaun Claydon was previously a director of Destiny Pharma Limited ("Destiny") (formerly known as Destiny Pharma plc) until 30 September 2024. Destiny appointed an administrator on 21 August 2024 and was placed into creditors' voluntary liquidation on 1 August 2025.
お知らせ • Dec 17+ 2 more updatesFrontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.870588 million.Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.870588 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 4,487,658 Price\Range: £0.155 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,129,036 Price\Range: £0.155 Transaction Features: Regulation S; Subsequent Direct Listing
お知らせ • Dec 09Frontier IP Group Plc, Annual General Meeting, Dec 31, 2025Frontier IP Group Plc, Annual General Meeting, Dec 31, 2025. Location: the offices of addleshaw goddard llp, exchange tower, 19 canning street, eh3 9eh, edinburgh United Kingdom
お知らせ • Nov 09+ 1 more updateFrontier Ip Announces Resignation of Jo Stent as Director, Effective No Later Than 30 April 2026Frontier IP announced that Chief Financial Officer Jo Stent is to leave the Group to pursue an opportunity with a private equity backed specialist financial services provider. The Board of Frontier IP and Jo have agreed that Jo will step down as a director no later than 30 April 2026. The process to appoint a new Chief Financial Officer has commenced and an update will be provided in due course.
お知らせ • Sep 27Matthew White Decides to Leave as Chief Commercialisation Officer of Frontier IP Group Plc, Effective March 24, 2026Frontier IP Group Plc announced that Matthew White (Chief Commercialisation Officer) has decided to leave the Group to pursue an opportunity as Chief Executive Officer of a Cambridge based early-stage medical devices company. It is currently intended that Mr. White will remain with the Company as Chief Commercialisation Officer and an Executive Director of the Company until the end of his six month notice period on 24 March 2026.
お知らせ • Nov 26Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.47132 million.Frontier IP Group Plc has completed a Follow-on Equity Offering in the amount of £0.47132 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,683,286 Price\Range: £0.28
お知らせ • Nov 24Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £1 million.Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £1 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 3,571,428 Price\Range: £0.28
お知らせ • Nov 23+ 1 more updateFrontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £3.030431 million.Frontier IP Group Plc has filed a Follow-on Equity Offering in the amount of £3.030431 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 357,143 Price\Range: £0.28 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 9,422,968 Price\Range: £0.28 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,042,857 Price\Range: £0.28 Transaction Features: Regulation S; Subsequent Direct Listing
New Risk • Sep 30New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Revenue is less than US$5m (UK£816k revenue, or US$1.1m). Market cap is less than US$100m (€22.5m market cap, or US$25.2m).
お知らせ • Apr 12Frontier IP Group plc Announces CFO Changes, Effective from April 22, 2024Frontier IP Group Plc announced the appointment of Jo Stent as Chief Financial Officer with effect from 22 April 2024. Jo is a chartered accountant, having qualified at Ernst & Young, and brings nearly 30 years' experience in senior financial roles across a broad range of sectors and geographies. Jo was most recently CFO at AIM quoted Argentex Group Plc, provider of bespoke currency risk management and payment solutions, from February 2021 to January 2024. She was previously Chief Financial Officer of the European Tour and Ryder Cup Europe. She is also a former CFO of Vodafone Americas and previously held senior positions at Telus Communications and Deloitte. Jo has spent most of her career in blue chip global organisations. More recently her keen interest in technology, innovation and scale up has led her to focus on working alongside founder led growth organizations as both an executive and non-executive director in the listed and private sector. With effect from 22 April 2024, Jim Fish, current Chief Financial Officer of the Group, will move to a new position within the Group as Portfolio Finance Director where he will continue to support the Group's portfolio companies.
Reported Earnings • Mar 18First half 2024 earnings released: EPS: UK£0.027 (vs UK£0.005 in 1H 2023)First half 2024 results: EPS: UK£0.027 (up from UK£0.005 in 1H 2023). Net income: UK£1.49m (up 453% from 1H 2023).
New Risk • Mar 14New major risk - Revenue and earnings growthEarnings have declined by 6.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Earnings have declined by 6.4% per year over the past 5 years. Minor Risks Revenue is less than US$5m (UK£816k revenue, or US$1.0m). Market cap is less than US$100m (€27.6m market cap, or US$30.1m).
New Risk • Jan 25New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (€26.6m market cap, or US$28.9m).
Board Change • Jan 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Nigel Grierson was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Nov 29Frontier Ip Group plc Announces resignation of Jim Fish as Chief Financial OfficerFrontier IP Group Plc announced that Jim Fish has notified the Board of his intention to step down as Chief Financial Officer of the Group after 10 years of service. Jim, age 66, will remain as CFO and as a director of the Group through his six month notice period which will end no later than 31 May 2024. Jim will remain focused on running the Group's finance function and continue to support the Group during his six month notice period. Jim will also work to ensure the effective transition of his responsibilities to his successor with the intention that there will be an orderly handover period of three months. Following the appointment of a new Group CFO and the completion of the necessary handover period, Jim will take up a new position within the Group as Portfolio Finance Director where he will continue to support the portfolio companies and will report into the Group CEO. This change is in line with the Group's succession planning and the search for a new Group CFO has been initiated. A further announcement will be made in due course.
お知らせ • Nov 23Frontier IP Group Plc, Annual General Meeting, Dec 15, 2023Frontier IP Group Plc, Annual General Meeting, Dec 15, 2023, at 11:00 Coordinated Universal Time. Location: 93 George Street, Edinburgh, EH2 3ES United Kingdom United Kingdom Agenda: To receive the audited consolidated financial statements of the Company and its subsidiaries for the year ended 30 June 2023, together with the reports of the Directors and the Auditor thereon; to approve the report of the Board to the members on directors' remuneration for the year ended 30 June 2023; to consider Retirement and Re-appointment of Directors; to resolve not to fill the vacancy created by the retirement of Andrew Richmond as a Director and Chairman of the Company at the AGM, in accordance with the Articles of Association of the Company; to re-appoint BDO LLP as auditor of the Company to hold office until the conclusion of the next general meeting at which financial statements are laid before shareholders; to authorize the Directors to determine the auditor's remuneration; to consider Authority to allot shares; and to consider any other matters.
Reported Earnings • Nov 02Full year 2023 earnings released: UK£0.058 loss per share (vs UK£0.19 profit in FY 2022)Full year 2023 results: UK£0.058 loss per share (down from UK£0.19 profit in FY 2022). Net loss: UK£3.24m (down 132% from profit in FY 2022).
お知らせ • Oct 31Frontier IP Group plc Announces Board ChangesFrontier IP announced that Andrew Richmond, currently Non-Executive Chairman, will be stepping down from the board of Frontier IP having served on the board for more than 11 years. Andrew will remain on the board until the Company's next annual general meeting ("AGM"), expected to be held in December 2023, where he will not seek re-election as a director. Dame Julia King, Baroness Brown of Cambridge, who joined the Frontier IP board of directors in October 2021 and is currently the Senior Independent Director on the board, will assume the role of Chair with effect from the conclusion of the forthcoming AGM.
お知らせ • Oct 24Frontier IP Group Plc (AIM:FIPP) acquired 32.8% stake in Deakin Bio-Hybrid Materials Limited.Frontier IP Group Plc (AIM:FIPP) acquired 32.8% stake in Deakin Bio-Hybrid Materials Limited on October 23, 2023. Nick Athanas and George Payne of Allenby Capital Limited acted as financial advisor to Frontier IP Group. Frontier IP Group Plc (AIM:FIPP) completed the acquisition of 32.8% stake in Deakin Bio-Hybrid Materials Limited on October 23, 2023.
New Risk • Oct 01New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Revenue is less than US$5m (UK£2.9m revenue, or US$3.6m). Market cap is less than US$100m (€34.7m market cap, or US$36.7m).
New Risk • Jul 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Revenue is less than US$5m (UK£2.9m revenue, or US$3.8m). Market cap is less than US$100m (€28.7m market cap, or US$32.1m).
Reported Earnings • Mar 16First half 2023 earnings released: EPS: UK£0.005 (vs UK£0.14 in 1H 2022)First half 2023 results: EPS: UK£0.005 (down from UK£0.14 in 1H 2022). Revenue: UK£910.0k (down 93% from 1H 2022). Net income: UK£269.0k (down 97% from 1H 2022). Profit margin: 30% (down from 66% in 1H 2022). The decrease in margin was driven by lower revenue.
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 1 experienced director. 5 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Julia King was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Nov 11Frontier IP Group Plc, Annual General Meeting, Dec 09, 2022Frontier IP Group Plc, Annual General Meeting, Dec 09, 2022, at 11:00 Coordinated Universal Time. Location: 93 George Street, Edinburgh, EH2 3ES Edinburgh United Kingdom
Reported Earnings • Oct 28Full year 2022 earnings released: EPS: UK£0.19 (vs UK£0.17 in FY 2021)Full year 2022 results: EPS: UK£0.19 (up from UK£0.17 in FY 2021). Revenue: UK£14.1m (up 11% from FY 2021). Net income: UK£10.2m (up 6.9% from FY 2021). Profit margin: 73% (down from 76% in FY 2021). The decrease in margin was driven by higher expenses.
お知らせ • Aug 02Frontier IP Group Plc Common Shares to Be Deleted from OTC EquityFrontier IP Group Plc Common Shares (United Kingdom) will be deleted from OTC Equity effective from August 02, 2022, due to CUSIP Suspended.
Board Change • Apr 27Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 2 experienced directors. 4 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Julia King was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Mar 24Investor sentiment improved over the past weekAfter last week's 16% share price gain to €1.03, the stock trades at a trailing P/E ratio of 3.4x. Average trailing P/E is 14x in the Capital Markets industry in Germany.
Board Change • Dec 13Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Julia King was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Oct 29Full year 2021 earnings released: EPS UK£0.17 (vs UK£0.088 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: UK£12.7m (up 99% from FY 2020). Net income: UK£9.57m (up 129% from FY 2020). Profit margin: 76% (up from 66% in FY 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • Oct 21Investor sentiment improved over the past weekAfter last week's 16% share price gain to €1.42, the stock trades at a trailing P/E ratio of 13.1x. Average trailing P/E is 18x in the Capital Markets industry in Germany.
Board Change • Oct 02Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 4 experienced directors. 2 highly experienced directors. 2 independent directors (5 non-independent directors). Non-Executive & Independent Director Mike Bourne was the last independent director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
